English
Transgene Biotek Q4 Results
- BSE: 526139
- NSE: -
- ISIN: INE773D01018
- Sector: Biotechnology & Drugs
BSE
2.54
0.09 (3.67%)
0.09 (3.67%)Volume25.98 K
Updated: Thu 22 Jan, 2026 | 10:55:30
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Transgene Biotek Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.64 | 0.19 | 234.58% | 0.33 | 95.38% |
| Depreciation/ Amortization | 0.02 | 0.02 | 1.29% | 0.02 | 2.17% |
| Total Revenue | 0.08 | 0.08 | 0.00% | 0.05 | 70.00% |
| Operating Income | -0.57 | -0.12 | 389.96% | -0.28 | 99.40% |
| Net Income | -0.71 | -0.09 | 701.24% | -0.26 | 169.20% |
| Selling/ General/ Admin Expenses Total | 0.06 | 0.08 | -22.21% | 0.08 | -17.23% |
| Other Operating Expenses Total | 0.56 | 0.09 | 536.31% | 0.23 | 142.68% |
| Net Income Before Taxes | -0.71 | -0.09 | 701.24% | -0.26 | 169.20% |
| Diluted Normalized EPS | -0.09 | -0.01 | 700.94% | -0.04 | 144.12% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.